Systemic Lupus Erythematosus News and Research

RSS
Systemic lupus erythematosus (SLE) is the form of the disease that most people are referring to when they say "lupus." The word "systemic" means the disease can affect many parts of the body. The symptoms of SLE may be mild or serious. Although SLE usually first affects people between the ages of 15 and 45 years, it can occur in childhood or later in life as well.
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

Juvenile inflammatory rheumatic disease associated with higher antibody responses to seasonal coronaviruses

Inherited genetic variation may affect the response to cancer immunotherapy

Inherited genetic variation may affect the response to cancer immunotherapy

Researchers find possible cause for self-destructive immune system attacks in autoimmune diseases

Researchers find possible cause for self-destructive immune system attacks in autoimmune diseases

Systemic lupus erythematosus disproportionately affects ethnic female population

Systemic lupus erythematosus disproportionately affects ethnic female population

Study shows that risk of autoimmune disease lupus is higher in females

Study shows that risk of autoimmune disease lupus is higher in females

Common gene expression changes at target tissues of four autoimmune diseases found

Common gene expression changes at target tissues of four autoimmune diseases found

New approach can help identify novel treatments for autoimmune diseases

New approach can help identify novel treatments for autoimmune diseases

Steroids used to treat inflammatory disease increases risk of cardiovascular disease

Steroids used to treat inflammatory disease increases risk of cardiovascular disease

Mymee's clinical trial demonstrates health-related quality of life improvements in lupus patients

Mymee's clinical trial demonstrates health-related quality of life improvements in lupus patients

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Study: Hydroxychloroquine has no effect on abnormal heart rhythm in lupus patients with CKD

Black patients with lupus have higher risk of stroke and ischemic heart disease

Black patients with lupus have higher risk of stroke and ischemic heart disease

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Lupus patients receiving prophylactic therapy are at high risk for adverse reactions

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Patients with rheumatic diseases reported antimalarial drug shortages during COVID-19

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Hydroxychloroquine not associated with prolonged heart rhythm intervals in RA or lupus patients

Pre-existing anti-IFN autoantibodies may worsen COVID-19 in lupus patients

Pre-existing anti-IFN autoantibodies may worsen COVID-19 in lupus patients

Lung biomarkers may predict severe COVID-19

Lung biomarkers may predict severe COVID-19

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Auto-antibodies may explain why some people develop severe COVID-19

Auto-antibodies may explain why some people develop severe COVID-19

Targeted treatment for systemic lupus erythematosus

Targeted treatment for systemic lupus erythematosus